Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Prescribed Detraining to Decrease Atrial Fibrillation Burden and Symptoms in Athletes.

NCT03642886 is registered in ClinicalTrials.gov with Cardiology Research UBC as lead sponsor.

NCT NCT03642886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Prescribed Detraining to Decrease Atrial Fibrillation Burden and Symptoms in Athletes.
Lead sponsor
Cardiology Research UBC
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2018
Completion date
April 30, 2020
Enrollment
73 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation